Hydroxycarbamide-containing medicinal products - Important Safety Information from CHEPLAPHARM Arzneimittel GmbH as approved by the HPRA (20.09.24)

Notice type: 3rd Party Publications

Date: 20/09/2024




Problem Or Issue:

Important Safety Information from CHEPLAPHARM Arzneimittel regarding Hydroxycarbamide-containing medicinal products: Potential interference with continuous glucose monitoring systems


Important Safety Information – Hydroxycarbamide-containing medicinal products


« Back